{"lastClose": 4.53000020980835, "len": 1130, "date": "2023-04-10", "alpha_1": -0.4593910405841921, "beta_1": 1.526288452161248, "drawup_1": 1.5486725887776869, "natr_1": 17.812466373767517, "sup_1": -0.5172922583929563, "res_1": 0.027225786454085153, "bullPattern_1": [], "bearPattern_1": ["BELTHOLD", "ENGULFING", "LONGLINE"], "rsi_1": 21.8390869171368, "adx_1": 14.210696959842107, "drawdown_1": -0.7378472204975508, "stratHoldSharpe_1": -0.5545449200291931, "stratHoldAlpha_1": 250.6269175388078, "stratHoldDrawdown_1": -0.6972293090911472, "alpha_3mo": -0.8838827462505819, "beta_3mo": 1.5863461581215046, "drawup_3mo": 0.2888540322832984, "natr_3mo": 17.812466373767517, "sup_3mo": -0.012509238061624411, "res_3mo": 0.20676963471643822, "bullPattern_3mo": [], "bearPattern_3mo": ["BELTHOLD"], "rsi_3mo": 25.581415335242713, "adx_3mo": 30.083633041979965, "drawdown_3mo": -0.4482338381534542, "stratHoldSharpe_3mo": -2.8890740467193963, "stratHoldAlpha_3mo": 249.50296721905326, "stratHoldDrawdown_3mo": -0.40944490436983383, "Name": "Allogene Therapeutics Inc.", "Country": "United States", "IPO Year": 2018.0, "Market Cap": 654573145, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "alpha%_1": 0.08150594416230827, "beta%_1": 0.8721709039604364, "drawup%_1": 0.9972041881054484, "natr%_1": 0.9999999871133863, "drawdown%_1": 0.026712062594514883, "stratHoldSharpe%_1": 0.22949965878149775, "stratHoldAlpha%_1": 0.08193561098805047, "stratHoldDrawdown%_1": 0.01811489922826819, "alpha%_3mo": 0.09342467459601961, "beta%_3mo": 0.8119663603118064, "drawup%_3mo": 0.866852866581384, "natr%_3mo": 0.9999999776131647, "drawdown%_3mo": 0.016091125670782972, "stratHoldSharpe%_3mo": 0.06326696471803148, "stratHoldAlpha%_3mo": 0.009108109922691818, "stratHoldDrawdown%_3mo": 0.0157512323125058}